ArticleFrontiers in oncology2025

Mesenchymal stem cells added to second-line therapy improve response and failure-free survival in steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A meta-analysis of randomized controlled trials.

Man Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.